203 related articles for article (PubMed ID: 26177159)
1. Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity.
Gu J; Hu W; Zhang DD
J Cell Mol Med; 2015 Oct; 19(10):2324-8. PubMed ID: 26177159
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
Cote B; Carlson LJ; Rao DA; Alani AWG
J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
[TBL] [Abstract][Full Text] [Related]
3.
Yang Y; Wang W; Xiong Z; Kong J; Wang L; Qiu Y; Shen F; Huang Z
Pharmazie; 2016 Sep; 71(9):514-523. PubMed ID: 29441847
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
Gu J; Hu W; Song ZP; Chen YG; Zhang DD; Wang CQ
Int Immunopharmacol; 2016 Mar; 32():1-7. PubMed ID: 26774212
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B.
Tian W; Yang L; Liu Y; He J; Yang L; Zhang Q; Liu F; Li J; Liu J; Sumi S; Shen Y; Qi Z
J Nutr Biochem; 2020 May; 79():108132. PubMed ID: 30857673
[TBL] [Abstract][Full Text] [Related]
6. The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review.
Syahputra RA; Harahap U; Dalimunthe A; Nasution MP; Satria D
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209107
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway.
Yang L; Luo C; Chen C; Wang X; Shi W; Liu J
Br J Pharmacol; 2016 Jan; 173(2):357-71. PubMed ID: 26507774
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.
Arafa MH; Mohammad NS; Atteia HH; Abd-Elaziz HR
J Physiol Biochem; 2014 Sep; 70(3):701-11. PubMed ID: 24939721
[TBL] [Abstract][Full Text] [Related]
9. Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin.
De Francesco EM; Rocca C; Scavello F; Amelio D; Pasqua T; Rigiracciolo DC; Scarpelli A; Avino S; Cirillo F; Amodio N; Cerra MC; Maggiolini M; Angelone T
J Cell Physiol; 2017 Jul; 232(7):1640-1649. PubMed ID: 27607345
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis.
Sin TK; Tam BT; Yung BY; Yip SP; Chan LW; Wong CS; Ying M; Rudd JA; Siu PM
J Physiol; 2015 Apr; 593(8):1887-99. PubMed ID: 25665036
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.
Danz ED; Skramsted J; Henry N; Bennett JA; Keller RS
Free Radic Biol Med; 2009 Jun; 46(12):1589-97. PubMed ID: 19303434
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity.
Monahan DS; Flaherty E; Hameed A; Duffy GP
Biomed Pharmacother; 2021 Aug; 140():111702. PubMed ID: 34015579
[TBL] [Abstract][Full Text] [Related]
13. Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro.
Chu X; Zhang Y; Xue Y; Li Z; Shi J; Wang H; Chu L
Int Immunopharmacol; 2020 Jul; 84():106548. PubMed ID: 32388215
[TBL] [Abstract][Full Text] [Related]
14. Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin.
Koczurkiewicz-Adamczyk P; Klaś K; Gunia-Krzyżak A; Piska K; Andrysiak K; Stępniewski J; Lasota S; Wójcik-Pszczoła K; Dulak J; Madeja Z; Pękala E
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207549
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy.
Xu X; Chen K; Kobayashi S; Timm D; Liang Q
J Pharmacol Exp Ther; 2012 Apr; 341(1):183-95. PubMed ID: 22209892
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats.
Zhang YY; Yi M; Huang YP
Cell Physiol Biochem; 2017; 43(2):626-635. PubMed ID: 28946137
[TBL] [Abstract][Full Text] [Related]
17. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
Molecules; 2018 May; 23(5):. PubMed ID: 29762537
[TBL] [Abstract][Full Text] [Related]
18. Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.
Rezk YA; Balulad SS; Keller RS; Bennett JA
Am J Obstet Gynecol; 2006 May; 194(5):e23-6. PubMed ID: 16647892
[TBL] [Abstract][Full Text] [Related]
19. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
Ye M; Zhang L; Yan Y; Lin H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-κB signaling pathway.
Zhang C; Lin G; Wan W; Li X; Zeng B; Yang B; Huang C
Int J Mol Med; 2012 Apr; 29(4):557-63. PubMed ID: 22246136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
